(Q53910275)
Statements
A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy. (English)
T Betts
T Waegemans
P Crawford
1 March 2000
9
2
80-87